Open2.220 | Close2.120 |
Vol / Avg.126.405K / 18.685K | Mkt Cap103.978M |
Day Range1.990 - 2.380 | 52 Wk Range1.890 - 2.730 |
MediciNova Stock (NASDAQ: MNOV) stock price, news, charts, stock research, profile.
Open2.220 | Close2.120 |
Vol / Avg.126.405K / 18.685K | Mkt Cap103.978M |
Day Range1.990 - 2.380 | 52 Wk Range1.890 - 2.730 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2021-03-10 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 15.00 |
2020-03-13 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 22.00 | 11.00 |
2019-03-25 | B. Riley Securities | David Buck | Assumes | Buy | Announces | - | 22.00 |
2018-03-28 | B. Riley Securities | David Buck | Initiates Coverage On | Buy | Announces | - | 22.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MNOV | MediciNova | 1.44% | 104M |
IMNM | Immunome | 7.15% | 98.7M |
ANIX | Anixa Biosciences | -1.23% | 99.7M |
GALT | Galectin Therapeutics | 4.97% | 113.2M |
BNR | Burning Rock Biotech | 0.66% | 95.3M |
You can purchase shares of MediciNova (NASDAQ: MNOV) through any online brokerage.
Other companies in MediciNova’s space includes: Immunome (NASDAQ:IMNM), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), Burning Rock Biotech (NASDAQ:BNR) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for MediciNova (NASDAQ: MNOV) was reported by Maxim Group on Wednesday, March 10, 2021. The analyst firm set a price target for 15.00 expecting MNOV to rise to within 12 months (a possible 607.55% upside). 0 analyst firms have reported ratings in the last year.
The stock price for MediciNova (NASDAQ: MNOV) is $2.12 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for MediciNova.
MediciNova’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for MediciNova.
MediciNova is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MediciNova Stock (NASDAQ: MNOV) stock price, news, charts, stock research, profile.
Open2.220 | Close2.120 |
Vol / Avg.126.405K / 18.685K | Mkt Cap103.978M |
Day Range1.990 - 2.380 | 52 Wk Range1.890 - 2.730 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2021-03-10 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 15.00 |
2020-03-13 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 22.00 | 11.00 |
2019-03-25 | B. Riley Securities | David Buck | Assumes | Buy | Announces | - | 22.00 |
2018-03-28 | B. Riley Securities | David Buck | Initiates Coverage On | Buy | Announces | - | 22.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MNOV | MediciNova | 1.44% | 104M |
IMNM | Immunome | 7.15% | 98.7M |
ANIX | Anixa Biosciences | -1.23% | 99.7M |
GALT | Galectin Therapeutics | 4.97% | 113.2M |
BNR | Burning Rock Biotech | 0.66% | 95.3M |
You can purchase shares of MediciNova (NASDAQ: MNOV) through any online brokerage.
Other companies in MediciNova’s space includes: Immunome (NASDAQ:IMNM), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), Burning Rock Biotech (NASDAQ:BNR) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for MediciNova (NASDAQ: MNOV) was reported by Maxim Group on Wednesday, March 10, 2021. The analyst firm set a price target for 15.00 expecting MNOV to rise to within 12 months (a possible 607.55% upside). 0 analyst firms have reported ratings in the last year.
The stock price for MediciNova (NASDAQ: MNOV) is $2.12 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for MediciNova.
MediciNova’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for MediciNova.
MediciNova is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MediciNova Stock (NASDAQ: MNOV) stock price, news, charts, stock research, profile.
Open2.220 | Close2.120 |
Vol / Avg.126.405K / 18.685K | Mkt Cap103.978M |
Day Range1.990 - 2.380 | 52 Wk Range1.890 - 2.730 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2021-03-10 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 15.00 |
2020-03-13 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 22.00 | 11.00 |
2019-03-25 | B. Riley Securities | David Buck | Assumes | Buy | Announces | - | 22.00 |
2018-03-28 | B. Riley Securities | David Buck | Initiates Coverage On | Buy | Announces | - | 22.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MNOV | MediciNova | 1.44% | 104M |
IMNM | Immunome | 7.15% | 98.7M |
ANIX | Anixa Biosciences | -1.23% | 99.7M |
GALT | Galectin Therapeutics | 4.97% | 113.2M |
BNR | Burning Rock Biotech | 0.66% | 95.3M |
You can purchase shares of MediciNova (NASDAQ: MNOV) through any online brokerage.
Other companies in MediciNova’s space includes: Immunome (NASDAQ:IMNM), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), Burning Rock Biotech (NASDAQ:BNR) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for MediciNova (NASDAQ: MNOV) was reported by Maxim Group on Wednesday, March 10, 2021. The analyst firm set a price target for 15.00 expecting MNOV to rise to within 12 months (a possible 607.55% upside). 0 analyst firms have reported ratings in the last year.
The stock price for MediciNova (NASDAQ: MNOV) is $2.12 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for MediciNova.
MediciNova’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for MediciNova.
MediciNova is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MediciNova Stock (NASDAQ: MNOV) stock price, news, charts, stock research, profile.
Open2.220 | Close2.120 |
Vol / Avg.126.405K / 18.685K | Mkt Cap103.978M |
Day Range1.990 - 2.380 | 52 Wk Range1.890 - 2.730 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2021-03-10 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 15.00 |
2020-03-13 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 22.00 | 11.00 |
2019-03-25 | B. Riley Securities | David Buck | Assumes | Buy | Announces | - | 22.00 |
2018-03-28 | B. Riley Securities | David Buck | Initiates Coverage On | Buy | Announces | - | 22.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MNOV | MediciNova | 1.44% | 104M |
IMNM | Immunome | 7.15% | 98.7M |
ANIX | Anixa Biosciences | -1.23% | 99.7M |
GALT | Galectin Therapeutics | 4.97% | 113.2M |
BNR | Burning Rock Biotech | 0.66% | 95.3M |
You can purchase shares of MediciNova (NASDAQ: MNOV) through any online brokerage.
Other companies in MediciNova’s space includes: Immunome (NASDAQ:IMNM), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), Burning Rock Biotech (NASDAQ:BNR) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for MediciNova (NASDAQ: MNOV) was reported by Maxim Group on Wednesday, March 10, 2021. The analyst firm set a price target for 15.00 expecting MNOV to rise to within 12 months (a possible 607.55% upside). 0 analyst firms have reported ratings in the last year.
The stock price for MediciNova (NASDAQ: MNOV) is $2.12 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for MediciNova.
MediciNova’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for MediciNova.
MediciNova is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MediciNova Stock (NASDAQ: MNOV) stock price, news, charts, stock research, profile.
Open2.220 | Close2.120 |
Vol / Avg.126.405K / 18.685K | Mkt Cap103.978M |
Day Range1.990 - 2.380 | 52 Wk Range1.890 - 2.730 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2021-03-10 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 15.00 |
2020-03-13 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 22.00 | 11.00 |
2019-03-25 | B. Riley Securities | David Buck | Assumes | Buy | Announces | - | 22.00 |
2018-03-28 | B. Riley Securities | David Buck | Initiates Coverage On | Buy | Announces | - | 22.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MNOV | MediciNova | 1.44% | 104M |
IMNM | Immunome | 7.15% | 98.7M |
ANIX | Anixa Biosciences | -1.23% | 99.7M |
GALT | Galectin Therapeutics | 4.97% | 113.2M |
BNR | Burning Rock Biotech | 0.66% | 95.3M |
You can purchase shares of MediciNova (NASDAQ: MNOV) through any online brokerage.
Other companies in MediciNova’s space includes: Immunome (NASDAQ:IMNM), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), Burning Rock Biotech (NASDAQ:BNR) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for MediciNova (NASDAQ: MNOV) was reported by Maxim Group on Wednesday, March 10, 2021. The analyst firm set a price target for 15.00 expecting MNOV to rise to within 12 months (a possible 607.55% upside). 0 analyst firms have reported ratings in the last year.
The stock price for MediciNova (NASDAQ: MNOV) is $2.12 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for MediciNova.
MediciNova’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for MediciNova.
MediciNova is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MediciNova Stock (NASDAQ: MNOV) stock price, news, charts, stock research, profile.
Open2.220 | Close2.120 |
Vol / Avg.126.405K / 18.685K | Mkt Cap103.978M |
Day Range1.990 - 2.380 | 52 Wk Range1.890 - 2.730 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2021-03-10 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 15.00 |
2020-03-13 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 22.00 | 11.00 |
2019-03-25 | B. Riley Securities | David Buck | Assumes | Buy | Announces | - | 22.00 |
2018-03-28 | B. Riley Securities | David Buck | Initiates Coverage On | Buy | Announces | - | 22.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MNOV | MediciNova | 1.44% | 104M |
IMNM | Immunome | 7.15% | 98.7M |
ANIX | Anixa Biosciences | -1.23% | 99.7M |
GALT | Galectin Therapeutics | 4.97% | 113.2M |
BNR | Burning Rock Biotech | 0.66% | 95.3M |
You can purchase shares of MediciNova (NASDAQ: MNOV) through any online brokerage.
Other companies in MediciNova’s space includes: Immunome (NASDAQ:IMNM), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), Burning Rock Biotech (NASDAQ:BNR) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for MediciNova (NASDAQ: MNOV) was reported by Maxim Group on Wednesday, March 10, 2021. The analyst firm set a price target for 15.00 expecting MNOV to rise to within 12 months (a possible 607.55% upside). 0 analyst firms have reported ratings in the last year.
The stock price for MediciNova (NASDAQ: MNOV) is $2.12 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for MediciNova.
MediciNova’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for MediciNova.
MediciNova is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MediciNova Stock (NASDAQ: MNOV) stock price, news, charts, stock research, profile.
Open2.220 | Close2.120 |
Vol / Avg.126.405K / 18.685K | Mkt Cap103.978M |
Day Range1.990 - 2.380 | 52 Wk Range1.890 - 2.730 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2021-03-10 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 15.00 |
2020-03-13 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 22.00 | 11.00 |
2019-03-25 | B. Riley Securities | David Buck | Assumes | Buy | Announces | - | 22.00 |
2018-03-28 | B. Riley Securities | David Buck | Initiates Coverage On | Buy | Announces | - | 22.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MNOV | MediciNova | 1.44% | 104M |
IMNM | Immunome | 7.15% | 98.7M |
ANIX | Anixa Biosciences | -1.23% | 99.7M |
GALT | Galectin Therapeutics | 4.97% | 113.2M |
BNR | Burning Rock Biotech | 0.66% | 95.3M |
You can purchase shares of MediciNova (NASDAQ: MNOV) through any online brokerage.
Other companies in MediciNova’s space includes: Immunome (NASDAQ:IMNM), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), Burning Rock Biotech (NASDAQ:BNR) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for MediciNova (NASDAQ: MNOV) was reported by Maxim Group on Wednesday, March 10, 2021. The analyst firm set a price target for 15.00 expecting MNOV to rise to within 12 months (a possible 607.55% upside). 0 analyst firms have reported ratings in the last year.
The stock price for MediciNova (NASDAQ: MNOV) is $2.12 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for MediciNova.
MediciNova’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for MediciNova.
MediciNova is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MediciNova Stock (NASDAQ: MNOV) stock price, news, charts, stock research, profile.
Open2.220 | Close2.120 |
Vol / Avg.126.405K / 18.685K | Mkt Cap103.978M |
Day Range1.990 - 2.380 | 52 Wk Range1.890 - 2.730 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2021-03-10 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 15.00 |
2020-03-13 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 22.00 | 11.00 |
2019-03-25 | B. Riley Securities | David Buck | Assumes | Buy | Announces | - | 22.00 |
2018-03-28 | B. Riley Securities | David Buck | Initiates Coverage On | Buy | Announces | - | 22.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MNOV | MediciNova | 1.44% | 104M |
IMNM | Immunome | 7.15% | 98.7M |
ANIX | Anixa Biosciences | -1.23% | 99.7M |
GALT | Galectin Therapeutics | 4.97% | 113.2M |
BNR | Burning Rock Biotech | 0.66% | 95.3M |
You can purchase shares of MediciNova (NASDAQ: MNOV) through any online brokerage.
Other companies in MediciNova’s space includes: Immunome (NASDAQ:IMNM), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), Burning Rock Biotech (NASDAQ:BNR) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for MediciNova (NASDAQ: MNOV) was reported by Maxim Group on Wednesday, March 10, 2021. The analyst firm set a price target for 15.00 expecting MNOV to rise to within 12 months (a possible 607.55% upside). 0 analyst firms have reported ratings in the last year.
The stock price for MediciNova (NASDAQ: MNOV) is $2.12 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for MediciNova.
MediciNova’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for MediciNova.
MediciNova is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MediciNova Stock (NASDAQ: MNOV) stock price, news, charts, stock research, profile.
Open2.220 | Close2.120 |
Vol / Avg.126.405K / 18.685K | Mkt Cap103.978M |
Day Range1.990 - 2.380 | 52 Wk Range1.890 - 2.730 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2021-03-10 | Maxim Group | Jason McCarthy | Initiates Coverage On | Buy | Announces | - | 15.00 |
2020-03-13 | B. Riley Securities | Mayank Mamtani | Maintains | Buy | Lowers | 22.00 | 11.00 |
2019-03-25 | B. Riley Securities | David Buck | Assumes | Buy | Announces | - | 22.00 |
2018-03-28 | B. Riley Securities | David Buck | Initiates Coverage On | Buy | Announces | - | 22.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MNOV | MediciNova | 1.44% | 104M |
IMNM | Immunome | 7.15% | 98.7M |
ANIX | Anixa Biosciences | -1.23% | 99.7M |
GALT | Galectin Therapeutics | 4.97% | 113.2M |
BNR | Burning Rock Biotech | 0.66% | 95.3M |
You can purchase shares of MediciNova (NASDAQ: MNOV) through any online brokerage.
Other companies in MediciNova’s space includes: Immunome (NASDAQ:IMNM), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), Burning Rock Biotech (NASDAQ:BNR) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for MediciNova (NASDAQ: MNOV) was reported by Maxim Group on Wednesday, March 10, 2021. The analyst firm set a price target for 15.00 expecting MNOV to rise to within 12 months (a possible 607.55% upside). 0 analyst firms have reported ratings in the last year.
The stock price for MediciNova (NASDAQ: MNOV) is $2.12 last updated September 28, 2023 at 8:00 PM UTC.
There is no dividend information for MediciNova.
MediciNova’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for MediciNova.
MediciNova is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.